GM Advisory Group, LLC - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 27 filers reported holding GEMPHIRE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GM Advisory Group, LLC ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$17,000
-51.4%
43,3350.0%0.01%
-54.5%
Q2 2019$35,000
-30.0%
43,3350.0%0.01%
-31.2%
Q1 2019$50,000
+42.9%
43,3350.0%0.02%
+23.1%
Q4 2018$35,000
-60.7%
43,3350.0%0.01%
-53.6%
Q3 2018$89,000
-79.9%
43,3350.0%0.03%
-78.6%
Q2 2018$442,000
+90.5%
43,335
+21.4%
0.13%
+87.1%
Q1 2018$232,000
-18.3%
35,6850.0%0.07%
-9.1%
Q4 2017$284,000
-16.2%
35,6850.0%0.08%
-25.2%
Q3 2017$339,000
-25.8%
35,6850.0%0.10%
-28.5%
Q2 2017$457,00035,6850.14%
Other shareholders
GEMPHIRE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Exchange Capital Management, Inc. 536,281$3,491,0001.10%
Stonepine Capital Management, LLC 242,812$1,581,0000.85%
NORTHPOINTE CAPITAL LLC 779,109$5,072,0000.64%
Cormorant Asset Management, LP 1,041,635$6,781,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 481,046$3,132,0000.48%
DAFNA Capital Management LLC 100,000$651,0000.32%
Telemetry Investments, L.L.C. 35,571$232,0000.09%
GM Advisory Group, LLC 35,685$232,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 107,479$700,0000.04%
OAKVIEW CAPITAL MANAGEMENT, L.P. 19,200$124,0000.03%
View complete list of GEMPHIRE THERAPEUTICS INC shareholders